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At the onset of mitosis, the Golgi complex undergoes a multistep fragmentation process that is required for its correct
partitioning into the daughter cells. Inhibition of this Golgi fragmentation results in cell cycle arrest at the G2 stage,
suggesting that correct inheritance of the Golgi complex is monitored by a “Golgi mitotic checkpoint.” However, the
molecular basis of this G2 block is not known. Here, we show that the G2-speciﬁc Golgi fragmentation stage is
concomitant with centrosome recruitment and activation of the mitotic kinase Aurora-A, an essential regulator for entry
into mitosis. We show that a block of Golgi partitioning impairs centrosome recruitment and activation of Aurora-A,
which results in the G2 block of cell cycle progression. Overexpression of Aurora-A overrides this cell cycle block,
indicating that Aurora-A is a major effector of the Golgi checkpoint. Our ﬁndings provide the basis for further
understanding of the signaling pathways that coordinate organelle inheritance and cell duplication.
INTRODUCTION
The Golgi complex has a crucial role in the processing and
transport of cellular proteins and lipids. In mammalian cells,
the Golgi complex is organized as a continuous membra-
nous system that comprises stacks interconnected by tu-
bules, a structure known as the “Golgi ribbon” (Shorter and
Warren, 2002). The mitotic inheritance of the Golgi complex
involves progressive and reversible disassembly of this
Golgi ribbon into dispersed elements through a multistage
process (Shorter and Warren, 2002; Colanzi et al., 2003; Al-
tan-Bonnet et al., 2004). This must be precisely regulated for
the optimal distribution of a functional Golgi complex to
each of the daughter cells. The ﬁrst step in this Golgi disas-
sembly is the fragmentation of the noncompact zones of the
Golgi ribbon. This occurs in G2 and results in the formation
of isolated Golgi stacks (Colanzi et al., 2007; Feinstein and
Linstedt, 2007). Importantly, this severing of the Golgi rib-
bon is necessary for entry into mitosis (Sutterlin et al., 2002;
Hidalgo Carcedo et al., 2004; Colanzi and Corda, 2007; Col-
anzi et al., 2007; Feinstein and Linstedt, 2007).
A functional block of the proteins involved in this Golgi
fragmentation step, such as the ﬁssioning protein CtBP1-S/
BARS (henceforth referred to as BARS) (Hidalgo Carcedo et
al., 2004; Corda et al., 2006) and the Golgi matrix components
GRASP65 (Sutterlin et al., 2002) and GRASP55 (Duran et al.,
2008), results in inhibition of the severing of the Golgi ribbon
and arrest of the cell cycle at the G2 stage (Sutterlin et al.,
2002; Hidalgo Carcedo et al., 2004; Yoshimura et al., 2005).
Inhibition or depletion of the kinases that control this Golgi
fragmentation, such as Raf1, Mek1 and Erk1c, also results in
a signiﬁcant delay in G2/M transition (Acharya et al., 1998;
Colanzi et al., 2003; Shaul and Seger, 2006; Feinstein and
Linstedt, 2007). Once in mitosis, the Golgi stacks undergo
further fragmentation, which is independent of BARS (Col-
anzi et al., 2007) and Mek1 (Feinstein and Linstedt, 2007) and
is controlled by Cdk1 and Polo-like kinase1 (Plk1) (Wang et
al., 2005; Colanzi and Corda, 2007).
Therefore, a “Golgi mitotic checkpoint” is dedicated to
linking the state of (dis)assembly of the Golgi complex with
entry into mitosis (Colanzi and Corda, 2007; Rabouille and
Kondylis, 2007). The molecular mechanisms connecting
Golgi fragmentation to regulation of mitotic progression are
however not known, and their elucidation has the potential
for identiﬁcation of novel proteins/mechanisms that are
involved in the overall maintenance of the structure and
function of the Golgi complex and in cell cycle regulation.
Here, we show that severing of the Golgi ribbon during
G2 is concomitant to centrosome separation and to centro-
some recruitment and activation of the mitotic kinase Auro-
ra-A (Aur-A), an essential regulator of entry into mitosis
(Hirota et al., 2003; Seki et al., 2008). To identify the cell cycle
proteins that are targeted by the Golgi checkpoint, we in-
duced an acute block of Golgi partitioning in cells synchro-
nized for mitotic ingression and analyzed the functional
consequences of this inhibition of Golgi fragmentation. We
ﬁnd that a block in Golgi partitioning induces strong im-
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3708pairment of recruitment and activation of Aur-A at the
centrosome, and this results in a block of cell entry into
mitosis. Overexpression of Aur-A can overcome the cell
cycle block induced by inhibition of Golgi fragmentation,
indicating that this kinase is a major effector of this Golgi
checkpoint.
These ﬁndings provide the basis for deﬁning the mecha-
nisms by which the ﬁdelity of Golgi complex partitioning is
monitored, and therefore how this controls G2/M transition.
This has important physiological and pharmacological con-
sequences, because characterization of this pathway will
help in the identiﬁcation and validation of novel target(s) for
antiproliferative therapies and cancer treatment.
MATERIALS AND METHODS
Cell Culture
Normal rat kidney (NRK) and HeLa cells were from the American Type
Culture Collection (Manassas, VA) and were respectively cultured in DMEM
and minimal essential medium (Invitrogen, Carlsbad, CA), supplemented
with 10% fetal calf serum (Biochrom, Berlin, Germany), 1% MEM nonessential
amino acids solution, 1% penicillin/streptomycin, and 1% l-glutamine (In-
vitrogen). All cell lines were grown under controlled atmosphere in the
presence of 5% CO2 at 37°C.
Antibodies and Reagents
Aphidicolin and thymidine were from Sigma-Aldrich (Milan, Italy). Dimeth-
ylsulfoxide (DMSO) was from Carlo Erba (Italy). RO-3306 and SB203058 were
from Calbiochem (Darmstadt, Germany); SB-218078 was from Tocris Bio-
science (Bristol, UK); UCN-01, anisomycin, etoposide, and topotecan were
from Sigma-Aldrich. MLN8054 was kindly provided by J. Ecsedy (Millen-
nium Pharmaceuticals, Cambridge, MA). Pak kinase inhibitor IPA3 was
kindly provided by Dr. Jonathan Chernoff (Fox Chase Cancer Center, Phila-
delphia, PA). Fluorescein isothiocyanate (FITC)- and tetramethylrhodamine B
isothiocyanate (TRITC)-labeled dextran and Hoechst 33342 were from Invitro-
gen; DRAQ5 was from Enzo Life Sciences (Lausen, Switzerland); and Mowiol
was from Calbiochem. Antibodies were from the following sources: Aurora-A,
Myt1, phospho-Aurora-A (Thr288), p38 mitogen-activated protein (MAP) kinase,
phospho-p38 MAP kinase (Thr180/Tyr182), phospho-Cdc25C (Ser216), and
phospho-Pak1(Ser199/204)/Pak2 (Ser192/197) (Cell Signaling Technology, Dan-
vers, MA); Aurora A, green ﬂuorescent protein (GFP), Plk1, and pericentrin
(Abcam, Cambridge, MA); phospho-histone H3 (Ser10) (Millipore, Billerica, MA);
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), -tubulin, and phos-
pho-Pak1/2/3 (Thr423) (Sigma-Aldrich); GM130 (BD Biosciences, San Jose,
CA); CtBP1/BARS and giantin (kindly provided by M. A. De Matteis, Con-
sorzio Mario Negri Sud, Italy); and Alexa 488-, Alexa 633- and Alexa 546-
conjugated secondary antibodies (Invitrogen).
Immunoﬂuorescence Microscopy
HeLa cells were grown on 10 g/ml ﬁbronectin-coated glass coverslips
(Sigma-Aldrich) and treated as described above. They were then either ﬁxed
with 4% paraformaldehyde (Electron Microscopy Sciences, Hatﬁeld, PA) for
10 min at room temperature or with methanol for 5 min at –20°C. The
blocking reagent (0.5% bovine serum albumin, 0.1% saponin, and 50 mM
NH4Cl) was then added to the cells for 20 min, followed by a 1-h incubation
with the primary antibody in the blocking reagent. The cells were then
washed with phosphate-buffered saline and incubated with secondary anti-
bodies (1:400) with 2 g/ml Hoechst 33342 and/or 5 M DRAQ5.
Microinjection and Cell Cycle Synchronization
For morphological and mitotic index analysis of synchronized cells, HeLa
cells were plated at 60% conﬂuence on 15-mm coverslips. For the double-
thymidine cell cycle arrest, the cells were maintained in growth medium plus
2 mM thymidine for 16 h and then rinsed and maintained in growth medium
for 8 h. The cells were then maintained in thymidine for an additional 16 h
before the ﬁnal release of the cell cycle arrest. At various times after this
release (6–13 h), the cells were ﬁxed and their DNA was labeled with either
2 g/ml Hoechst 33342 or 5 M DRAQ5, and with the appropriate antibodies,
depending on experimental conditions. The mitotic index was estimated by
measuring the number of cells showing clear mitotic (condensed chromo-
somes) and interphase (diffuse nuclear staining) features, under an Axiophot
microscope (Carl Zeiss, Gottingen, Germany) equipped with a 63 objective.
For microinjection experiments, the puriﬁed recombinant proteins (8–12 mg/
ml) were mixed with 0.4 mg/ml FITC- or TRICT-labeled dextran (Invitrogen),
as tracers of microinjection, and microinjected into 200–600 HeLa cells 30 min
after removal of the S phase block. The cells were then incubated in complete
medium for the appropriate times, before ﬁxing. The cells were stained with
the DNA dyes Hoechst 33342 or DRAQ5, and with the appropriate antibodies,
depending on experimental conditions. For G2 phase cell cycle arrest, HeLa
cells were subjected to a single thymidine arrest for 16 h and then rinsed and
maintained in growth medium plus 40 g/ml Hoechst 33258 for additional
18 h. Statistical signiﬁcance of the measurements was assessed by two-tailed
Student’s t test.
Cell Transfection and RNA Interference
HeLa cells were transfected with the TransIT-LT1 Transfection Reagent (Mi-
rus, Madison, WI), according to the manufacturer’s instructions. The cells
were microinjected 24 h after transfection, and processed for immunoﬂuores-
cence at the mitotic peak. An anti-GFP polyclonal antibody was used to
enhance the transfection signal. Small interfering RNA (siRNA) duplexes
were transfected using Lipofectamine 2000 (Invitrogen), according to the
manufacturer’s instructions. The Golgi protein GM130 was targeted using
siRNA duplexes directed against the sequence AAGTTAGAGATGACG-
GAACTC (Dharmacon RNA Technologies, Lafayette, CO). Myt1 protein ki-
nase was targeted using a siGENOME SMARTpool (M-005026-02-0005; Dhar-
macon RNA Technologies). p38 MAP kinase was targeted using an siRNA
pool (SignalSilence Pool p38 MAP kinase siRNA; Cell Signaling Technology).
BARS was targeted using siGENOME SMARTpool (M-008609-01; Dharmacon
RNA Technologies). Nontargeting siRNA sequences were used as controls
(Dharmacon RNA Technologies). After transfection, the intracellular protein
contents were assessed by SDS-polyacrylamide gel electrophoresis followed
by Western blotting, and the cells were further processed according to the
experimental design.
Microscopy
Cells were imaged with a confocal laser microscope (LSM510 META confocal
microscope system, Carl Zeiss; objective: 63  1.4 numerical aperture [NA]
oil; deﬁnition: 512  512 pixels; pinhole diameter: 1 Airy unit for each
emission channel; acquisition LSM510 software: LSM 510 [3.2]). For quanti-
tative analysis of Aur-A and phospho-Aur-A on centrosomes, the images
were acquired using identical confocal settings. Cells also were imaged using
a DM5000-B ﬂuorescence microscope and acquisition software FW4000 V
1.2.1. (both Leica, Wetzlar, Germany). Images were cropped and optimized
for brightness and contrast with Photoshop and composed using Illustrator
(Adobe Systems, Mountain View, CA).
Quantiﬁcation of Aurora-A Fluorescence Intensity
Cells were imaged with a confocal laser microscope (LSM710, Carl Zeiss;
objective: 63  1.4 NA oil; deﬁnition: 1024  1024 pixels). The bright centro-
somal regions identiﬁed by a centrosome marker were circled, the Aurora-A
ﬂuorescence intensity in these regions and in a similarly sized background
region were determined using LSM710 software (ZEN 2008 SP1), and the
Aurora-A centrosomal ﬂuorescence was calculated from these values.
RESULTS
Severing of the Golgi Ribbon during G2 Is Coincident
with Centrosome Separation
The molecular dissection of the signaling pathways connect-
ing Golgi fragmentation to the regulation of mitotic progres-
sion requires ﬁrst the identiﬁcation of the cell cycle proteins
that are targeted by the Golgi checkpoint. For this, we used
a microinjection-based experimental approach to induce an
acute block of Golgi partitioning in cells synchronized for
mitotic ingression, and a single-cell immunoﬂuorescence-
based analysis of the functional consequences of this inhibi-
tion of Golgi fragmentation. This demanding experimental
approach was essential to focus our observations on pro-
cesses that are precisely regulated and that occur over lim-
ited space and time and to reduce the intervention of poten-
tial compensatory mechanisms.
To inhibit the G2-speciﬁc severing of the Golgi ribbon,
HeLa cells were microinjected with recombinant proteins or
antibodies aimed at interfering with the function of either
BARS, a protein essential for the G2-speciﬁc ﬁssion of the
tubular membranes connecting the Golgi stacks (Hidalgo
Carcedo et al., 2004; Colanzi et al., 2007), or GRASP65, a
Golgi-associated protein that is involved in the maintenance
of Golgi structure and function (Sutterlin et al., 2002)
through a BARS-independent mechanism (Colanzi and
Corda, 2007). This microinjection-based approach has al-
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inducing speciﬁc, potent and persistent Golgi-dependent G2
block (Sutterlin et al., 2002; Hidalgo Carcedo et al., 2004).
HeLa cells were seeded on glass coverslips and synchro-
nized for cell cycle arrest at the G1/S boundary by double-
thymidine S phase block (Colanzi et al., 2007). After the
release of this S phase block by thymidine washout, the
number of cells in mitosis increased with time, peaking 12 h
after the removal of thymidine (mitotic peak) (Figure 1A).
During a time frame corresponding to S phase, 200 cells on
each coverslip were microinjected with generic immuno-
globulin (Ig)Gs as a control or with an anti-BARS blocking
antibody to block Golgi fragmentation (Figure 1B). In addi-
tion, the cells also were injected with puriﬁed recombinant
glutathione transferase (GST) as a control, with the recom-
binant BARS deletion mutant corresponding to the BARS
substrate-binding domain (SBD) (Hidalgo Carcedo et al.,
2004) or with the recombinant cis-Golgi protein GRASP65
(Sutterlin et al., 2002). These two recombinant proteins acted
as dominant-negative mutants and inhibited Golgi fragmen-
tation (Supplemental Figure S1) (Sutterlin et al., 2002;
Hidalgo Carcedo et al., 2004). The cells were ﬁxed at the
mitotic peak (12 h after S phase release) to evaluate the
number of cells in mitosis (Figure 1B), as described previ-
ously (Hidalgo Carcedo et al., 2004). The injection of generic
IgGs or GST did not alter mitotic entry, whereas microinjec-
tion of the anti-BARS antibody, SBD, or GRASP65 resulted
in strong inhibition of the mitotic index (Figure 1C), indicat-
ing that the HeLa cells used in this study are responsive to
the Golgi checkpoint. Furthermore, to test whether inhibi-
tion of Golgi fragmentation causes a delay or a block in
G2/mitotic progression, we set up a different mitotic assay.
Double-thymidine synchronized HeLa cells where injected
with generic IgGs or anti-BARS antibodies and ﬁxed 7 h
after they had passed their mitotic peak (Figure 1B; 19 h after
thymidine washout). Cells that had completed mitosis were
identiﬁed as cell couplets that shared the injected ﬂuorescent
marker (Figure 1D, top). Because the count of cell couplets
included all of the mitotic events that had occurred during
the experimental time frame, this represents a cumulative
mitotic index. In the cell population injected with generic
IgGs, 80% of the cells were found as couplets (Figure 1D,
top; and E). Conversely, in the cell population injected with
the anti-BARS antibody, the majority of the cells were in the
form of single cells (not duplicated; Figure 1D, bottom), and
20% were found as cell couplets (Figure 1E). More than
Figure 1. Inhibition of Golgi fragmentation causes a block of cell cycle progression in HeLa cells. (A) Quantiﬁcation of the mitotic index of
cells grown on coverslips and arrested in S phase using the double-thymidine block, as shown schematically in B. The cells were ﬁxed at the
indicated times after the S phase block release, the DNA was labeled with Hoechst-33342, and the mitotic indices were calculated under
ﬂuorescence microscopy (see Materials and Methods). (C) Quantiﬁcation of cells treated as illustrated in B. One hour after the S phase block
release, the cells were microinjected with ﬂuorescent dextran as injection marker, together with recombinant GST (8 mg/ml), generic IgGs
(5 mg/ml), recombinant SBD (8–12 mg/ml), an anti-BARS antibody (Ab-BARS; 5–7 mg/ml), or recombinant GRASP65 (GR65; 8–10 mg/ml).
The cells were ﬁxed at the mitotic peak (12 h after S phase release) and processed for immunoﬂuorescence under confocal microscopy, with
DRAQ5 (blue) for the cell cycle phase. The relative mitotic indices were calculated as percentages of microinjected cells in mitosis normalized
to nonmicroinjected cells on the same coverslip. (D and E) HeLa cells were treated as described in C with microinjections with generic IgGs
(5 mg/ml) and the anti-BARS antibody (Ab-BARS; 5–7 mg/ml). The cells were ﬁxed 19 h after the S phase block release and processed for
immunoﬂuorescence under confocal microscopy, with ﬂuorescently labeled secondary antibodies to reveal IgG- or anti-BARS-injected cells.
(D) Representative images of post-mitotic couplets (top) and premitotic singlets (bottom), microinjected as indicated. Bar, 10 m. (E)
Quantiﬁcation of duplication index as percentages of postmitotic couplets (see Materials and Methods). Quantiﬁcation data are means  SD
from two (A and E) and four (C) independent experiments, each carried out in duplicate. More than 200 cells were microinjected for each
condition.
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ered at the end of the experiment, suggesting that during the
time frame of the experiment, only a minor fraction had
been lost as a result of induction of an apoptotic response
(data not shown). In line with an essential role of Golgi
fragmentation for entry into mitosis, siRNA-mediated de-
pletion of BARS (Supplemental Figure S2A) reduced the
levels of BARS by 80% (Supplemental Figure S2B), and this
caused a strong reduction of the mitotic index (Supplemen-
tal Figure S2C) and of the mitotic-speciﬁc phosphorylation
of the histone H3 (Supplemental Figure S2B). Therefore, the
important role of the Golgi checkpoint is shown by this
induction of persistent cell cycle arrest.
Because the inhibition of the severing of the Golgi ribbon
induces a cell cycle block in G2 (Sutterlin et al., 2002; Hidalgo
Carcedo et al., 2004), this must affect the signaling processes
that govern the activation of the cyclin B–Cdk1 complex
(cycB-Cdk1), the master regulator of entry into mitosis
(Nigg, 2001). The ﬁrst activation of cycB-Cdk1 occurs at the
centrosome during G2, in coincidence with centrosome sep-
aration, and before the hallmarks of mitotic entry become
morphologically discernible, such as chromosome conden-
sation and assembly of mitotic spindles (Hirota et al., 2003;
Jackman et al., 2003). In HeLa cells, the S phase Golgi ribbon
(identiﬁed using an anti-giantin antibody; Figure 2A, S
phase) was located in close association with the duplicated
centrosomes (identiﬁed using an anti--tubulin antibody;
Figure 2A). During early G2 phase (identiﬁed using an
anti-phospho-H3 antibody; Figure 6A), the centrosomes be-
gan to separate (Figure 2A; G2 phase, arrows), and this
coincided with the ﬁrst evident severing of the Golgi ribbon
(i.e., the Golgi fragmentation step essential for mitotic en-
trance). The Golgi complex thus appeared to be divided into
two main groups of isolated membranes, each of which
maintained close association with a separated centrosome
(Figure 2A, G2 phase). The centrosomes reached their ﬁnal
positions in prophase (Figure 2A, prophase), in preparation
for the formation of the mitotic spindles (Nigg, 2001).
Thus, because during G2 the severing of the Golgi ribbon
seemed to be coordinated with the movement of the sepa-
rating centrosomes, we explored the hypothesis that a block
in this Golgi partitioning affects the mechanisms governing
the centrosomal activation of cycB-Cdk1. The earliest essen-
tial event for this activation is the recruitment and activation
of the kinase Aur-A at the centrosome (Fu et al., 2007). Aur-A
is activated by either autophosphorylation or Pak1-medi-
ated transphosphorylation on T288 in its activation domain
(Figure 2Ba; Zhao et al., 2005). This phosphorylation, and
thus Aur-A activity, is protected from the action of phos-
phatases (e.g., PP1) through Aur-A binding to scaffolding
proteins, such as HEF1 and Ajuba, which are components of
the focal adhesion complexes (Figure 2Ba; Hirota et al., 2003;
Pugacheva and Golemis, 2005). Once activated, Aur-A di-
rectly phosphorylates Cdc25B phosphatase (Figure 2Bb;
Cazales et al., 2005) and Plk1 (Figure 2Bc), which in turn
phosphorylates Cdc25C phosphatase (Figure 2Bd; Seki et al.,
2008). The two phosphatases then together activate the cy-
cB–Cdk1 complex, which leads to irreversible entry into
mitosis (Figure 2Be; Jackman et al., 2003). Plk1 is another
important regulator of mitotic entry (Nigg, 2001). However,
a possible contribution of Plk1 to Aur-A activation is still
under debate (Figure 2Bc, dashed arrow; Chan et al., 2008).
Finally, negative regulation of mitotic entry is operated by
stress-damage– or DNA-damage–activated checkpoints; by
acting through the kinases p38 (Cha et al., 2007) and Chk1
(Lofﬂer et al., 2007), Cdc25B can be phosphorylated, which
leads to its inhibition (Figure 2B, g and h). In addition, Chk1
can also inhibit Aur-A (targeting its Ser342) (Figure 2Bf;
Krystyniak et al., 2006).
A Block of Golgi Fragmentation Results in Inhibition of
Aur-A Recruitment to and Activation at the Centrosomes
To determine whether and how the block of Golgi fragmen-
tation affects the mechanisms governing centrosomal activa-
tion of cycB-Cdk1, we systematically tested whether the
Golgi-dependent cell cycle block is mediated by one or more
of the mechanisms depicted in Figure 2B. We ﬁrst focused
on the mitotic kinase Aur-A, because it is the ﬁrst known cell
cycle component to be activated at the centrosome during
early G2, and it has been shown to have an essential role for
entry into mitosis (Hirota et al., 2003; Cazales et al., 2005; Seki
et al., 2008). Thus, we determined the kinetics of Aur-A
activation at the centrosome in HeLa cells that had been
synchronized by the double-thymidine S phase block (Col-
anzi et al., 2007). Active Aur-A was identiﬁed by its phos-
phorylation on T288, by taking advantage of a well-charac-
terized anti-phospho-T288-Aur-A antibody (Figure 3A;
Hirota et al., 2003). Active Aur-A was detected at the cen-
trosome (Figure 3A, G2 phase and prophase) 6 h after re-
lease of the S phase block (Figure 3B), and its signal in-
creased gradually and became detectable at the spindle
(Figure 3A, metaphase) with progression into the mitotic
phase of the cell cycle (Figure 3B). Importantly, cells with
active Aur-A detected on unseparated centrosomes (Figure
3C, top), corresponding to the earliest stage of Aur-A re-
cruitment, did not show evident alterations of Golgi struc-
ture (Figure 3C, bottom), indicating that Aur-A activation
precedes the initial severing of the Golgi ribbon.
HeLa cells were subjected to the double-thymidine syn-
chronization protocol and injected with FITC-dextran, as
injection marker, together with GST, SBD, or GRASP65. The
cells were ﬁxed at the mitotic peak and stained with the
antibody against active T288-phosphorylated Aur-A, to de-
Figure 2. Morphology of Golgi membranes and centrosomes
through the cell cycle in HeLa cells. (A) Representative images of
cells grown on coverslips and processed for immunoﬂuorescence
under confocal microscopy 12 h after the S phase block release. The
cells were labeled with antibodies against giantin (red; Golgi com-
plex) and -tubulin (green) to mark the centrosomes (arrows) at the
indicated cell cycle stages. Images were acquired at maximal reso-
lution, with ﬁxed imaging conditions. Bars, 5 m. (B) Schematic
representation of the mechanisms governing activation of cycB-
Cdk1 at the centrosome during G2. See text for details.
Aurora-A Regulation by Golgi Partitioning
Vol. 21, November 1, 2010 3711termine the percentage of cells with active Aur-A at the
centrosome. Injection of GST did not affect Aur-A activation
(Figure 3E, GST-inj). Conversely, injection of SBD (Figure
3D) and GRASP65 reduced the proportion of cells with
active centrosome-located Aur-A by 60–70% (Figure 3E,
SBD-inj, GR65-inj), showing that a block of Golgi fragmen-
tation reduces Aur-A activation. In line with an essential role
for Aur-A in G2/mitosis progression, the treatment of syn-
chronized cells for 4 h with 0.25 M of the Aur-A inhibitor
MLN8054 (MLN) reduced both the proportion of cells with
active Aur-A (Figure 3E, MNL), and the mitotic index (Fig-
ure 3F, MLN).
Next, we tested whether the block of Golgi fragmentation
also affects recruitment of Aur-A to the centrosome, which is
the step that precedes its activation (Hirota et al., 2003).
Aur-A became detectable at the centrosomes of synchro-
nized HeLa cells (Figure 4A) 6 h after S phase block release
(Figure 4B). The percentage of cells with Aur-A detectable at
the centrosomes (Figure 4A, G2 phase and prophase) and
the spindle (Figure 4A, metaphase) increased with progres-
sion into the mitotic phases (Figure 4B). In line with the
timing of Aur-A activation, cells with Aur-A detected at the
duplicated centrosomes did not show structural alterations
of the Golgi complex (Figure 4C). Thus, HeLa cells were
synchronized by the double-thymidine block and microin-
jected with GST, SBD, or GRASP65 after thymidine washout.
The cells were again ﬁxed at the mitotic peak and stained
with antibodies to Aur-A to determine the percentages of
cells with Aur-A on the centrosome. In addition, SBD-in-
jected cells were also ﬁxed 8 and 10 h after thymidine
washout. As a control, injection of GST did not affect Aur-A
recruitment (Figure 4E, GST-inj), whereas microinjection of
either of these inhibitors of Golgi fragmentation (SBD,
GRASP65) induced 50% reduction in the proportion of
cells with detectable levels of Aur-A on the centrosomes
(Figure 4, D and E). This Golgi-dependent inhibition of
Aur-A recruitment was already evident at early time points
after thymidine washout (Figure 4E), indicating that inhibition
Figure 3. Inhibition of Golgi fragmentation blocks Aur-A activation at the centrosomes in HeLa cells. Cells were grown on coverslips and
processed for immunoﬂuorescence under confocal microscopy after the S phase block release. (A) Representative images of cells at the
indicated cell cycle stages, labeled with antibodies against -tubulin (green, arrow), and with DRAQ5 (blue) for cell cycle phase (top), and
labeled with antibodies against T288-phosphorylated Aur-A (red, arrow; bottom). (B) Quantiﬁcation of cells as described in A, with
pT288-Aur-A–positive cells calculated as percentages of cells with active T288-phosphorylated Aur-A at the centrosome (dark gray bars) and
the spindle (light gray bars), at the indicated times. (C) Representative images of cells 8 h after thymidine washout, labeled with antibodies
against T288-phosphorylated Aur-A (red, arrow), and labeled with antibodies against giantin (green) for the Golgi complex, and with DRAQ5
(blue) for cell cycle phase. (D–F) The cells were either nonmicroinjected or microinjected 1 h after thymidine washout, with recombinant GST
(GST-inj; 8 mg/ml), recombinant SBD (SBD-inj; 8–12 mg/ml), or recombinant GRASP65 (GR65-inj; 8–10 mg/ml), and with FITC-conjugated
dextran as microinjection marker. For the noninjected cells, 8 h after the S phase block release they were treated with vehicle () or 0.25 M
MLN8054 (MLN). The cells were then processed 12 h after the S phase block release for immunoﬂuorescence under confocal microscopy with
antibodies against T288-phosphorylated Aur-A and with DRAQ5 (for cell cycle phase). (D) Representative images of noninjected and
SBD-injected cells. (E) The relative percentages of PT288 Aur-A–positive cells were calculated according to the relevant nonmicroinjected cells
on the same coverslip (see Materials and Methods) or to cells treated with vehicle (). (F) Quantiﬁcation of the mitotic index of cells treated
with MLN. All images were acquired at maximal resolution, with ﬁxed imaging conditions. Quantiﬁcation data are means  SD from two
(B and F) and four (E) independent experiments, each carried out in duplicate. More than 200 cells were microinjected for each condition.
Bar, 5 m.
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reduction in Aur-A recruitment to the centrosomes. Treat-
ment of synchronized cells for 4 h with the Aur-A inhib-
itor (0.25 M MLN8054) did not affect Aur-A recruitment
to the centrosome (Figure 4E, MLN), indicating that the
kinase activity of Aur-A is not necessary for its localiza-
tion. Next, we assessed the effect of the inhibition of Golgi
fragmentation on the ﬂuorescence intensity of Aur-A in a
region of interest deﬁned by pericentrin-stained centro-
somes (Figure 4F, circle). As expected, the injection of
either SBD or GRASP65 reduced the fraction of cells with
above-background levels of Aur-A on the centrosomes,
compared with dextran-injected cells (Figure 4G). In ad-
dition, this quantitative analysis of Aur-A recruitment
showed that the injection of the blockers of Golgi frag-
mentation also signiﬁcantly reduced the total Aur-A ﬂu-
orescence intensity measured in the Aur-A–positive cen-
trosomes (Figure 4H). Therefore, our ﬁndings also
indicate that the Aur-A regulators HEF1 and Ajuba (Fig-
ure 2Ba) cannot be targets of the Golgi checkpoint, be-
cause they affect the activation status of Aur-A rather than
its recruitment (Hirota et al., 2003; Pugacheva and Gole-
mis, 2005). Although Aur-A is recruited to the centrosome
before the Golgi ribbon is fragmented (Figure 4C), our
data are compatible with mechanisms that either reduce
the rate of recruitment or accelerate the rate of release
from the centrosomes when Golgi fragmentation is
blocked, because centrosomal Aur-A has been shown to
undergo fast dynamic exchange with the Aur-A cytoplas-
mic pool, with a half-life of 3 s (Stenoien et al., 2003). In
addition, cold-induced microtubule depolymerization
suppressed Aur-A localization at the spindle, but did not
affect the G2-speciﬁc centrosome localization of Aur-A,
indicating that this centrosome localization is microtubule
independent (data not shown). Thus, these ﬁndings also
exclude that the Golgi checkpoint is mediated by TPX2,
Figure 4. Inhibition of Golgi fragmentation
blocks Aur-A recruitment to the centrosomes
in HeLa cells. Cells were grown on coverslips
and arrested in S phase using the double-thy-
midine block and processed for immunoﬂuo-
rescence under confocal microscopy. (A) Rep-
resentative images of cells at the indicated cell
cycle stages, labeled with antibodies against
-tubulin (green, arrow) and with DRAQ5
(blue) for cell cycle phase, and labeled with
antibodies against Aur-A (red, arrow). (B)
Quantiﬁcation of cells as described in A, with
percentages of Aur-A positive cells calculated
as percentages of cells with Aur-A at the cen-
trosome (dark gray bars) and the spindle (light
gray bars), at the indicated times. (C) Repre-
sentative images of cells 8 h after thymidine
washout, labeled with antibodies against gian-
tin (green) for the Golgi complex, and with
DRAQ5 (blue) for cell cycle phase, and labeled
with antibodies against Aur-A (red, arrow). (D
and E) The cells were either nonmicroinjected
or microinjected 1 h after thymidine washout
with recombinant GST (GST-inj; 8 mg/ml), re-
combinant SBD (SBD-inj; 8–12 mg/ml), or re-
combinant GRASP65 (GR65-inj; 8–10 mg/ml),
and with FITC-conjugated dextran as microin-
jection marker. For the noninjected cells, 8 h
after thymidine washout they were treated
with vehicle () or 0.25 M MLN8054 (MLN).
The cells were then processed 8 h, 10 h (SBD-
injected cells only) and 12 h (all of the cells)
after thymidine washout, for immunoﬂuores-
cence under confocal microscopy with anti-
bodies against Aur-A and with DRAQ5 (for
cell cycle phase). (D) Representative images of
noninjected and SBD-injected cells. (E) The rel-
ative percentages of Aur-A–positive cells were
calculated according to the relevant nonmicro-
injected cells on the same coverslip (see Mate-
rials and Methods), or to cells treated with
vehicle (). All images were acquired at max-
imal resolution, with ﬁxed imaging conditions. Bars, 5 m. Quantiﬁcation data are means  SD from two (B) and three (E) independent
experiments, each carried out in duplicate. More than 200 cells were microinjected for each condition. (F) Representative images of cells 12 h
after thymidine washout, labeled with antibodies against pericentrin (green) as a centrosome marker, and with Aurora-A (red). Insets are
higher magniﬁcation views of representative centrosomes. Equal areas were used to select the centrosome regions (circle) and a noncentro-
some region with a similar background (dashed circle). (G) Fluorescence intensity (a.u., arbitrary units) of centrosome-associated Aur-A per
cell was quantiﬁed by using LSM 710 ZEN 2008 SP1 (see Materials and Methods) in cells that had been treated as described in A and injected
with FITC-dextran alone (Dx-inj) or in the presence of SBD (SBD-inj) or GRASP65 (GR65-inj). One data set representative of three independent
experiments is shown as a scatter plot. More than 250 cells where injected and analyzed. (H) Fluorescence intensity SEM of the samples
reported in (G) that showed above-background ﬂuorescence levels of centrosome-associated Aur-A. Two-tailed Student’s t tests were applied
to the data (*p  0.005; **p  0.001). Bar, 5 m.
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required for recruiting Aur-A to the spindle (Kufer et al.,
2002).
A Block of Golgi Fragmentation Inhibits Aur-A
Recruitment and Activation through a Novel Mechanism
Because many signaling networks are composed of elements
that are functionally connected by feedback loops, it was
important to determine whether reduction of Aur-A recruit-
ment to and activation at the centrosome is a secondary
consequence of a block of the essential mitotic complex
cycB-Cdk1. Indeed, although according to some reports
Aur-A activation is independent of Cdk1 activity (Hirota et
al., 2003), other reports have proposed that Aur-A is acti-
vated downstream of cycB-Cdk1 (Marumoto et al., 2002).
HeLa cells were subjected to the double-thymidine synchro-
nization protocol, and 4 h after thymidine washout they
were incubated with 9 M RO-3306 (RO), a speciﬁc inhibitor
of Cdk1 kinase (Vassilev, 2006). The cells were ﬁxed at
various times after thymidine washout and stained with
Hoechst to determine the mitotic index and with antibodies
against the active T288-phosphorylated Aur-A. A similar set
of samples was treated for immunoblotting, to reveal the
levels of total and active Aur-A. Despite a complete block of
entry into mitosis in the RO-treated cells (Figure 5A), acti-
vation of Aur-A at the centrosome was not affected by RO
addition (Figure 5B). Conversely, this treatment strongly
reduced the global levels of active Aur-A (Figure 5C). Thus,
through this single-cell analysis and in our experimental
setting, early activation of Aur-A at the centrosome (i.e.,
during the G2 phase) is independent of cycB-Cdk1. This
centrosome pool of active Aur-A represents a minimal yet
functionally signiﬁcant fraction that is below the detection
limits of Western blotting. On the contrary, the global levels
of active Aur-A become detectable by Western blotting only
during the mitotic phase, and they were inﬂuenced by a
positive feedback loop that includes cycB-Cdk1. More im-
portantly, these data show that Golgi-dependent inhibition
of Aur-A activation cannot be mediated by a signaling path-
way that primarily affects cycB-Cdk1.
Next, we tested whether the block of Golgi fragmentation
affects the centrosomal activation of Pak1 (Figure 2Ba),
which has been shown to be the upstream activating kinase
that is involved in the ﬁrst activation of Aur-A at the cen-
trosome (Zhao et al., 2005). HeLa cells were again subjected
to the double-thymidine synchronization protocol and in-
jected with GRASP65 or incubated for 4 h with 30 Mo ft h e
Pak inhibitor IPA3 (Viaud and Peterson, 2009), until they
were ﬁxed at the mitotic peak. In line with the established
role of Pak, IPA3 reduced the fraction of cells with detectable
levels of active Aur-A by 35% (Figure 5D, IPA3). Pak
activation was monitored by confocal microscopy using an
antibody against a Pak autophosphorylation site, phospho-
Pak1/2/3 (T423) (Supplemental Figure S3A; Zhao et al.,
2005). The effectiveness of IPA3 was seen by its 50% reduc-
tion in the number of cells with active Pak at the centrosome
(Figure 5E and Supplemental Figure S3B). However, inhibi-
tion of Golgi fragmentation did not reduce the number of
cells with detectable levels of active Pak on the centrosome
(Figure 5E and Supplemental Figure S3C, GR65-inj). Similar
results were observed using another antibody raised against
different autophosphorylation sites, anti-phospho-Pak1/
2(S199/204) (data not shown). The lack of effect on Pak
activation indicates that a block of Golgi fragmentation does
not cause a generic inhibition of centrosome-located mitotic
kinases and that Pak is not targeted by the Golgi checkpoint.
Aur-A has recently been shown to be the upstream regu-
latory kinase of Plk1 (Figure 2Bc), another centrosome-local-
ized kinase (Supplemental Figure S3D) with essential roles
in mitosis (Seki et al., 2008). This phosphorylation of Plk1 is
enhanced by the interaction between Plk1 and Bora, a G2/
M-expressed protein that controls the accessibility of the
Figure 5. Block of Golgi fragmentation inhibits Aur-A
recruitment through a novel mechanism. HeLa cells
were grown on coverslips and arrested in S phase by
using the double-thymidine block. (A–C) Four hours
after S phase block release, the cells were either left in
growth medium (nontreated) or treated with 9 M
RO-3306 (a Cdk1 inhibitor) and ﬁxed and processed for
immunoﬂuorescence under confocal microscopy or im-
munoblotting at the indicated times after thymidine
removal. Cells were labeled with Hoechst 33342 to de-
termine the mitotic indices up to 12 h after S phase
release (A) and with antibodies against T288-phosphor-
ylated Aur-A to determine the relative percentages of
pT288 Aur-A–positive cells calculated according to the
nontreated cells ﬁxed up to 12 h after S phase release
(B). A similar set of samples was processed for immu-
noblotting to reveal total Aur-A and active Aur-A
(PT288) (C). (D–F) Cells were either nonmicroinjected
(D and E) or microinjected 1 h after thymidine washout
with recombinant GST (GST-inj; 8 mg/ml) or recombi-
nant GRASP65 (GR65-inj, 8–10 mg/ml; E and F), and
with FITC-conjugated dextran as microinjection marker
(E and F). Eight hours after S phase block release, the
nonmicroinjected cells were either left in growth me-
dium (D and E, ) or treated with 30 M IPA3 (D and
E, a Pak inhibitor) and ﬁxed 12 h after the S-phase block
release for immunoﬂuorescence under confocal microscopy with antibodies against T288-phosphorylated Aur-A (D), against T423-phos-
phorylated Pak (E), or against Plk1 (F). The relative percentages of PT288 Aur-A-positive (D), T423 Pak-positive (E) were calculated according
to the relevant cells treated with vehicle (). The relative percentages of Plk1-positive cells (F) were calculated according the noninjected cells
on the same coverslip. Quantiﬁcation data are means  SD from at least two independent experiments, each carried out in duplicate. More
than 200 cells were microinjected for each condition.
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Aur-A (Seki et al., 2008). During mitosis, Plk1-dependent
Bora degradation promotes Aur-A localization to the cen-
trosome and/or spindle, suggesting that Plk1 can also, in
turn, control Aur-A localization by regulating the levels of
Bora (Chan et al., 2008). Thus, the synergistic actions of
Aur-A, Bora, and Plk1 might, in principle, create a complex
regulatory circuit that controls G2/M transition (Figure
2Bc). Moreover, Plk1 has been implicated in mitotic Golgi
fragmentation (Sutterlin et al., 2001), suggesting that a Plk1-
dependent signaling mechanism might link Golgi partition-
ing and cell cycle control (Preisinger et al., 2005). Thus, we
tested the possible involvement of Plk1 in the Golgi check-
point by injecting GRASP65 in synchronized cells, to mea-
sure the effects of this on Plk1. Our analysis revealed that
inhibition of Golgi fragmentation did not impede the re-
cruitment of Plk1 to the centrosome (Figure 5F). However,
we could not test whether the block of Golgi fragmentation
affects the activation of Plk1, because the available anti-
phospho-Plk1 antibody was not sufﬁciently sensitive to de-
tect by immunoﬂuorescence the active form of Plk1 during
G2 (data not shown).
Thus, to further address a possible involvement of Plk1 in
the Golgi checkpoint, we followed a different strategy. We
ﬁrst monitored whether a block of Golgi fragmentation can
inﬂuence other typical mitotic features, such as the separa-
tion of the centrosomes and the percentages of cells with
nuclear phosphorylation of histone H3. The cells were sub-
jected to the double-thymidine synchronization protocol,
and 1 h after thymidine washout, they were microinjected
with recombinant GRASP65, or 8 h after the S block release,
they were incubated with the Aur-A inhibitor (0.25 M
MLN8054; Hoar et al., 2007), or with a Plk1 inhibitor (100 nM
BI2536; Steegmaier et al., 2007), until they were ﬁxed at the
mitotic peak. The cells were treated for immunoﬂuorescence
to reveal -tubulin and phosphorylated histone H3 (Figure
6A). The injection of GRASP65 did not reduce the propor-
tion of cells with disconnected centrosomes (separated 1
m; Figure 6B), indicating that the cells had passed S phase
(Jackman et al., 2003). However, this treatment reduced the
proportion of G2 cells (cells with uncondensed chromatin)
with detectable levels of nuclear phosphorylation of histone
H3 (Figure 6C, GR65-inj). It has been suggested that Aur-A
is not directly involved in this phosphorylation, because 24 h
of treatment of HCT-116 cells with 0.25 M MLN did not
reduce the fraction of mitotic cells positive to phosphory-
lated histone H3 (Manfredi et al., 2007). Thus, we tested the
effect of an “acute” inhibition of Aur-A on the phosphory-
lation of histone H3 seen in a G2 population of HeLa cells.
The cells were subjected to the double-thymidine synchro-
nization protocol and incubated for 4 h with 0.25 M
MLN8054 or with 100 nM BI2536 until they were ﬁxed at the
mitotic peak. This treatment with MLN8054 caused an 80%
reduction of cells with phosphorylated histone H3 seen in
the G2 phase (i.e., cells with uncondensed chromatin; Figure
6C, MLN), suggesting that similar to the Golgi checkpoint,
acute inhibition of Aur-A reduced, although perhaps indi-
rectly, the fraction of cells in G2 with detectable levels of
phosphorylation of histone H3. Conversely, the Plk1 inhib-
itor BI2536 did not affect this phosphorylation (Figure 6C,
BI), indicating that Plk1 activity does not correlate with the
mitotic features associated with the Golgi checkpoint. Fi-
nally, treatment of double-thymidine synchronized cells for
4 h with 100 nM BI2536 did not affect recruitment of Aur-A
to the centrosome (Figure 6D), further supporting the con-
cept that the Golgi checkpoint does not reduce Aur-A re-
cruitment through inhibition of Plk1. In line with this con-
clusion, Plk1 seems to be involved in the disassembly of the
Golgi stacks (Wang et al., 2005), which is a fragmentation
step that follows the Golgi checkpoint (Colanzi et al., 2007;
Feinstein and Linstedt, 2007). Together, our ﬁndings further
indicate that Aur-A is a major target of G2 arrest induced by
a block of Golgi fragmentation.
Injection of Golgi Fragmentation Blockers Reduces Aur-A
Recruitment Only in Cells with an Intact Golgi Ribbon
Although we microinjected two unrelated proteins to inhibit
Golgi fragmentation, the possibility that SBD and GRASP65
affect Aur-A localization in ways that are not related to Golgi
fragmentation was not formally ruled out by these data. To
Figure 6. Block of Golgi fragmentation does not re-
quire Plk1 to inhibit Aur-A recruitment. Cells were
grown on coverslips and arrested in S phase using the
double-thymidine block and processed for immunoﬂu-
orescence under confocal microscopy. (A) Representa-
tive images of cells at the indicated cell cycle stages,
labeled with an antibody against -tubulin (green, ar-
row) and with DRAQ5 (data not shown) for cell cycle
phase, and labeled with antibodies against phosphory-
lated histone H3 (p-H3, red). (B and C) The cells were
either nonmicroinjected or microinjected 1 h after thy-
midine washout with recombinant GST (GST-inj, 8 mg/
ml), or recombinant GRASP65 (GR65-inj, 8–10 mg/ml),
and with FITC-conjugated dextran as microinjection
marker. For the noninjected cells, 8 h after thymidine
washout they were treated with vehicle () or 0.25 M
MLN8054 (MLN), or with 100 nM BI2536 (BI). The cells
were then processed 12 h after thymidine washout, for
immunoﬂuorescence under confocal microscopy with
antibodies against -tubulin (B) or phosphorylated hi-
stone H3 (C). The relative percentages of cells with
separated centrosomes (B) or positive for phosphory-
lated histone H3 (C) were calculated according to the relevant nonmicroinjected cells on the same coverslip or to cells treated with vehicle
(). (D) Eight hours after S phase block release, the cells were either left in growth medium () or treated with 100 nM BI2536 (BI), ﬁxed at
the mitotic peak (at 12 h) and labeled with antibodies against T288-phosphorylated Aur-A. The relative percentages of PT288 Aur-A–positive
cells were calculated according to the cells treated with dilution buffer (). Quantiﬁcation data are means  SD from at least two independent
experiments, each carried out in duplicate. More than 200 cells were microinjected for each condition. Bar, 5 m.
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their Golgi complex divided into isolated stacks at all cell
cycle stages bypass the need for BARS and GRASP65 for
Golgi fragmentation and mitotic entrance (Colanzi et al.,
2007; Feinstein and Linstedt, 2007). As a result, such cells are
not blocked in G2 when microinjected with SBD (Colanzi et
al., 2007) or GRASP65 (Sutterlin et al., 2002). Accordingly,
microinjection of SBD or GRASP65 should inhibit Aur-A
recruitment to the centrosome only in cells that have an
intact Golgi ribbon, whereas this should not affect Aur-A
recruitment to the centrosomes when the organization of the
Golgi ribbon has already been disrupted. Therefore, here we
used siRNA-mediated depletion of the Golgi matrix protein
GM130, because GM130-depleted cells show Golgi mem-
branes in the form of isolated, but fully functional, minis-
tacks that are clustered around the nucleus (Marra et al.,
2007). According to our experimental conditions, we re-
duced GM130 expression to levels that were low enough
(Figure 7A) to cause the severing of the Golgi ribbon (Figure
7B), whereas not affecting the centrosome morphology (Ko-
dani et al., 2009). Importantly, the microinjection of SBD or
GRASP65 into these GM130-depleted cells failed to inhibit
entry into mitosis (Figure 7C, GM130 siRNA) and centro-
some recruitment of Aur-A (Figure 7, D and E, GM130
siRNA); the same treatments with nontargeting-siRNA-
treated cells were still able to reduce entry into mitosis and
recruitment of Aur-A (Figure 7, C–E, nontargeting). These
data show that injection of SBD or GRASP65 blocks Aur-A
activation only in cells that have an intact Golgi ribbon. This
excludes the concept that these microinjected proteins per se
affect Aur-A directly or through some other nonspeciﬁc
effects, and more importantly, it establishes a causal link
between inhibition of the severing of the Golgi ribbon in G2
and block of Aur-A recruitment to and activation at the
centrosomes.
Therefore, the block of the ﬁrst stage of the partitioning
process, the severing of the Golgi ribbon into separate stacks
in G2, speciﬁcally inhibits Aur-A recruitment to and activa-
tion at the centrosome, causing a general reduction in the
mitotic kinases.
Overexpression of Aur-A Can Override the Golgi
Checkpoint
Having established that a block of Golgi fragmentation in-
hibits activation of Aur-A at the centrosomes, we tested
whether inhibition of Aur-A is the major cause of the result-
ing G2 block. If this is the case, the overexpression of wild-
type (wt)-Aur-A should bypass the cell cycle block induced
by impaired Golgi fragmentation. Indeed, overexpression of
wt-Aur-A does not modify cell cycle progression under
normal conditions (Marumoto et al., 2002), although it is an
effective approach to override the DNA-damage checkpoint
induced by double-strand breaks (Krystyniak et al., 2006).
Thus, HeLa cells were transfected with the GFP-tagged
forms of Aur-A and Plk1, or with the empty vector as a
control, and subjected to the double-thymidine S phase syn-
chronization protocol. AurA overexpression did not induce
evident alterations in the structure of the Golgi complex
(Figure 8A). After the release from synchronization, the
transfected GFP-Aur-A localized to the centrosome and was
activated (Figure 8B). Importantly, and in line with a major
role for Aur-A in the Golgi checkpoint, the overexpression of
GFP-Aur-A induced a substantial overriding of the G2 block
that resulted from the inhibition of Golgi fragmentation
(Figure 8C, GFP-Aur-A). Conversely, the overexpression of
the kinase GFP-Plk1 did not override the Golgi-dependent
cell cycle block (Figure 8C, GFP-Plk1), indicating that ge-
neric overexpression of a mitotic kinase is not sufﬁcient to
nonspeciﬁcally force the cell cycle and bypass the Golgi
checkpoint.
To test whether Aur-A expression cause Golgi fragmen-
tation, we used a quantitative approach to analyze the state
of integrity of the Golgi complex using an immunoﬂuores-
cence-based measure of the number of “Golgi objects” in
interphase and G2-blocked cells (Feinstein and Linstedt,
2007). We found that Aur-A overexpression did not cause
Figure 7. Blockers of Golgi fragmentation do not affect
Aur-A recruitment to the centrosomes in HeLa cells
without an intact Golgi ribbon. Cells were grown on
coverslips and transfected for 48 h with 100 nM non-
targeting siRNAs (i.e., with intact Golgi ribbon) or 100
nM GM130-directed siRNAs (i.e., with isolated Golgi
stacks). (A) Representative experiment of cells pro-
cessed for immunoblotting of GM130 knockdown, as
revealed with antibodies against GM130 and against
GAPDH. (B) Representative images of cells from A
labeled with an anti-giantin antibody (green) for the
structure of the Golgi complex. (C–E) Alternatively, the
cells were arrested in S phase using the double-thymi-
dine block. One hour after thymidine washout, the cells
were either nonmicroinjected (noninj) or microinjected
with recombinant SBD (SBD-inj, 8–12 mg/ml) or re-
combinant GRASP65 (GR65-inj, 8–10 mg/ml), and with
FITC-conjugated dextran as microinjection marker. (C)
Relative mitotic indices of cells nonmicroinjected (non-
inj) or microinjected with recombinant SBD (SBD-inj).
(D) Representative images of cells ﬁxed 12 h after thy-
midine washout and processed for immunoﬂuores-
cence under confocal microscopy with antibodies
against Aur-A (red; for cells positive for Aur-A on
centrosomes; arrow) and with Hoechst 33342 (for cell
cycle phase). (E) Quantiﬁcation of cells as described
in D, with Aur-A–positive cells calculated as percent-
ages of microinjected cells with Aur-A on the centro-
somes normalized to nonmicroinjected cells on the same coverslip. Data are means  SD from three independent experiments, each
carried out in duplicate. More than 200 cells were microinjected for each condition. Bar, 5 m.
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untransfected or mock-transfected cells. Moreover, the num-
ber of Golgi objects found in Aur-A–overexpressing cells
was signiﬁcantly lower (25%) than the objects detectable in
G2-blocked cells (Supplemental Figure S4, A and B). In
addition, we also tested whether Aur-A inhibition can re-
duce Golgi fragmentation in a well-characterized assay for
Golgi fragmentation (Acharya et al., 1998) and found that the
Aur-A inhibitor MLN did not block Golgi fragmentation
even if used at high concentration (Supplemental Figure S4,
C and D). Collectively, these data indicate that Aur-A is not
involved in Golgi fragmentation, and they exclude the pos-
sibility that Aur-A overexpression overrides the Golgi
checkpoint by inducing Golgi fragmentation.
Known G2 Checkpoints Are Not Involved in the
Golgi-dependent Block of the Cell Cycle
Finally, we asked whether other signaling pathways that are
known to regulate cycB-Cdk1 are involved in inducing the
Golgi-dependent G2-block. In addition to the signaling path-
ways that provide positive regulation of cycB-Cdk1, entry
into mitosis is controlled by negative regulatory signals that
are operated by DNA-damage (Nigg, 2001) and stress-re-
lated checkpoints (Bulavin et al., 2001). Thus, when damage
to a cell is detected, these negative regulatory signals can
activate signaling cascades that inhibit key regulatory ele-
ments of G2/M transition, such as Cdc25B (Cazales et al.,
2005), Aur-A (Krystyniak et al., 2006) and cycB-Cdk1 itself
(Nigg, 2001; Figure 2B, f–h). It has already been shown that
the kinases ataxia-telangiectasia mutated (ATM) and ATM
and Rad 3-related (ATR), which are key players in the DNA-
damage checkpoint (Nigg, 2001), are not involved in the
Golgi-dependent cell cycle block (Sutterlin et al., 2002).
Moreover, induction of damage to DNA by etoposide inhib-
ited entry into mitosis (Supplemental Figure S5, A and B)
and Aur-A activation but did not alter Aur-A recruitment
(Supplemental Figure S5C), in agreement with previous
ﬁndings (Cazales et al., 2005). Nevertheless, we also investi-
gated whether the Golgi-dependent block of the cell cycle
could be mediated through activation of relevant compo-
nents of the DNA-damage checkpoint downstream of
ATM/ATR, i.e., the centrosome-located Chk1 (Lofﬂer et al.,
2007) or the Golgi-localized kinase Myt-1 (Nakajima et al.,
2008), all of which can provide negative regulation of cycB-
Cdk1 activation (Nigg, 2001; see below). If this is the case, it
should be possible to override the Golgi-dependent G2 block
by functional inhibition of Chk1 or Myt-1.
First, Chk1 is a downstream component of the DNA-
damage checkpoint that is located on the centrosome, where
it has been shown to inhibit Cdc25B (Lofﬂer et al., 2007) and
Aur-A (Krystyniak et al., 2006). Chk1 is the only kinase
known to date that can negatively regulate Aur-A (Krystyn-
iak et al., 2006); moreover, inhibition or depletion of Chk1 is
sufﬁcient to overcome the cell cycle block induced by DNA
damage (Lofﬂer et al., 2007). To address the involvement of
Chk1, we used two structurally unrelated and well charac-
terized inhibitors of Chk1: SB218078 (Tao and Lin, 2006) and
UCN-01 (Cazales et al., 2005), which effectively inhibited the
Chk1-mediated phosphorylation of Cdc25C (Supplemental
Figure S5D). The cells were subjected to the double-thymi-
dine synchronization protocol, microinjected with the SBD
recombinant protein, and 4 h after the S block release, they
were incubated with 2.5 M SB218078 or 300 nM UCN-01,
until they were ﬁxed at the mitotic peak. After ﬁxing, the
cells were labeled for the cell cycle phase with Hoechst
33342. However, inhibition of Chk1 did not bypass the Golgi
checkpoint (Figure 9, A and B), and we also did not see
recovery of Aur-A recruitment by inhibition of Chk1 (data
not shown).
Next, we examined the role of Myt1, a kinase that inhibits
cycB-Cdk1 through phosphorylation of both the T14 and
Y15 residues of Cdk1 and that is activated by DNA damage.
Importantly, Myt1 is localized at the Golgi complex and the
endoplasmic reticulum, and it has been shown to be in-
volved in both mitotic Golgi fragmentation (Cornwell et al.,
2002) and Golgi reassembly at telophase (Nakajima et al.,
2008). Consequently, Myt1 might have an important role in
the Golgi checkpoint and be hyperactivated by a block of
Golgi fragmentation. In this case, ablation of Myt1 should
bypass the G2 block after the induction of a block of Golgi
fragmentation. To test this hypothesis, we knocked down
Myt1 and tested whether this could override the Golgi
checkpoint. Treatment of cells with siRNA against Myt1 for
24 h was sufﬁcient to achieve an efﬁcient depletion of Myt1
(Supplemental Figure S6A) and override a DNA-damage–
mediated cell cycle block in G2 (Supplemental Figure S6, B
and C) without affecting the integrity of the Golgi ribbon
(data not shown). The cells were subjected to the double-
Figure 8. Overexpression of Aur-A can over-
ride the Golgi checkpoint in HeLa cells. HeLa
cells (A–C) were arrested in S phase by using
the double-thymidine block and transfected
for 24 h with the empty vector (GFP; C only),
GFP-Aur-A, or GFP-Plk1 (C only) after the ﬁrst
release from thymidine. (A) Representative
images of cells labeled with an antibody
against giantin (red) to label the Golgi com-
plex, with DRAQ5 (blue) for the cell cycle
phase. (B) Representative images of cells la-
beled with an antibody against phospho-T288-
Aur-A (red) and with DRAQ5 (blue) for the
cell cycle phase. (C) One hour after the ﬁnal
thymidine washout, the cells were either non-
microinjected (noninj) or microinjected with
recombinant GRASP65 (8–10 mg/ml), and
with TRITC-conjugated dextran as microinjec-
tion marker. The cells were ﬁxed 12 h after the ﬁnal thymidine washout, and processed for immunoﬂuorescence under confocal microscopy,
with antibodies against GFP to identify low transfection levels, and with Hoechst 33342 for cell cycle phase. Quantiﬁcation of the relative
mitotic index as percentages of microinjected cells in mitosis were normalized to nonmicroinjected cells on the same coverslip. More than 400
cells were microinjected for each condition. All quantiﬁcation data are means  SD from three independent experiments, each carried out
in duplicate. Bar, 5 m.
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and treated as described above. Again, the depletion of Myt1
did not overcome the Golgi checkpoint (Figure 9C). Together,
these data indicate that the components of the DNA-damage
checkpoint are not involved in the Golgi-dependent cell cycle
block and in the impairment of Aur-A recruitment to the
centrosome.
Finally, we examined the involvement of the known
stress-related G2 checkpoints. One of these checkpoints is
triggered by the ubiquitin ligase CHFR (Yu et al., 2005).
Because HeLa cells express a nonfunctional form of CHFR
(Yu et al., 2005), this pathway cannot be involved in the
Golgi checkpoint. Therefore, we focused on the other stress-
related checkpoints that are mediated by p38 kinase (Cha et
al., 2007), which is an MAP kinase component localized at
the centrosome and known to be activated in response to
various environmental stresses and to have an inhibitory
role on Cdc25B activity (Cha et al., 2007; see below). Here, we
used SB203580, a highly selective inhibitor of p38 that can
overcome the stress-dependent G2 checkpoint mediated by
p38 itself (Cirillo et al., 2002). To this purpose, HeLa cells
were subjected to the double-thymidine synchronization
protocol, microinjected with the GRASP65 recombinant pro-
tein, and 4 h after S block release, the cells were treated with
10 M SB203580, until they were ﬁxed at the mitotic peak.
The cells were then labeled for the cell cycle phase with
Hoechst 33342. This treatment resulted in an effective inhi-
bition of p38 autophosphorylation (Supplemental Figure
S7A) but in a negligible recovery of the G2 block in the cells
microinjected with GRASP65 (Figure 9D). Similar results
were obtained by knocking down p38 by RNA interference
(Supplemental Figure S7, B and C). Conversely, stimulation
of p38 by anisomycin (Cha et al., 2007) did not cause any
alteration of Aur-A recruitment at the centrosome (Supple-
mental Figure S7, D and E). Together, these data indicate
that the p38-mediated checkpoint should only have a minor
role, if any, in the Golgi checkpoint.
Thus, the Golgi checkpoint cannot be overridden by treat-
ments that can bypass the known G2 checkpoints. This
suggests further that Aur-A recruitment to and activation at
the centrosome is connected with the partitioning of the
Golgi ribbon through a novel signaling mechanism (Figure
10). Moreover, these last data again indicate that centrosome
located and activated Aur-A is a cell cycle component that
functions as the major effector of the Golgi checkpoint.
DISCUSSION
In the present study, we have used microinjection-based
assays to induce acute “damage” to Golgi partitioning as a
general experimental approach to investigate cell cycle pro-
teins that are “effectors” of the Golgi checkpoint.
Here, we have identiﬁed recruitment to and activation at
the centrosome of Aur-A kinase as the mitotic signaling step
that coordinates the partitioning of Golgi membranes with
the regulation of entry into mitosis. This conclusion is based
on the following evidence. First, the severing of the Golgi
ribbon during G2 (i.e., the fragmentation step that is essen-
tial for mitotic entrance) is concomitant with the initial re-
cruitment and activation of Aur-A kinase at the centro-
somes. Second, a block in Golgi partitioning leads to
reduced recruitment to and impaired activation at the cen-
trosome of Aur-A. The causal link between inhibition of the
severing of the Golgi ribbon in G2 and block of Aur-A
recruitment and activation is shown by the lack of inhibition
of Aur-A recruitment when the SBD and GRASP65 blockers
of Golgi fragmentation are microinjected into cells with a
fragmented Golgi ribbon. In addition, we have shown that
overexpression of Aur-A can overcome the cell cycle block
induced by inhibition of Golgi fragmentation, indicating
that Aur-A is a major effector of the Golgi checkpoint. Fi-
nally, we have shown that the Golgi-dependent G2 block is
not inﬂuenced by known G2 checkpoint mediators, nor is it
mediated by other kinases with essential roles in the activa-
tion of the cycB–Cdk1 complex, or by Golgi-localized cell
cycle regulators. Overall, our ﬁndings reveal the existence of
novel mechanisms that upon a block of Golgi fragmentation,
lead to inhibition of the recruitment of Aur-A to the centro-
Figure 9. The known G2 checkpoints are not involved in the
Golgi-dependent block of the cell cycle. HeLa cells (A, C, and D) and
NRK cells (B) were grown on coverslips and left untreated (C) or
arrested in S phase by using the double-thymidine block. (A and B)
One hour after S phase block release, the cells were microinjected (or
not; noninj) with recombinant SBD (8–12 mg/ml, SBD-inj) and
FITC-conjugated dextran as microinjection marker. Next, 4 h after S
phase block release the cells were either left untreated or treated
with 2.5 M SB218078 or 300 nM UCN-01. The cells were ﬁxed 12 h
after the ﬁnal thymidine washout and processed for immunoﬂuo-
rescence under confocal microscopy. (C) The cells were transfected
after the ﬁrst thymidine block of the cell synchronization protocol,
for 24 h with 20 nM nontargeting siRNAs or with 20 nM anti-Myt1
siRNAs, or processed without siRNAs transfection. One hour after
S phase block release, cells were microinjected (or not; noninj) with
recombinant GRASP65 (8–10 mg/ml), and FITC-conjugated dex-
tran as microinjection marker. (D) One hour after S phase block
release, cells were microinjected (or not; noninj) with recombinant
GRASP65 (8–10 mg/ml), and FITC-conjugated dextran as microin-
jection marker. After 4 h without thymidine, cells were either left
nontreated or treated with 10 M SB203580 (a p38 kinase inhibitor).
For all quantiﬁcation data (A–D), the cells were ﬁxed 12 h after the
second thymidine washout, processed for immunoﬂuorescence, and
observed under confocal microscopy, with labeling with Hoechst
33342 for cell cycle phase. Quantiﬁcation of the relative mitotic
indices is shown as percentages of microinjected cells in mitosis
normalized to nonmicroinjected cells on the same coverslip. More
than 200 cells were microinjected for each condition, and data are
means  SD from two (B) or three (A, C, and D) independent
experiments, each carried out in duplicate.
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indirectly on an Aur-A activator (Figure 10).
Aur-A is an oncogene that is overexpressed in several
human cancers, and it is required for multiple steps as cells
progress toward and through mitosis (Marumoto et al.,
2005). Aur-A expression increases as cells pass through S
phase; then during G2, Aur-A is recruited to the centro-
somes where it is activated (Marumoto et al., 2005). Once
activated, Aur-A directly phosphorylates Cdc25B phospha-
tase (Cazales et al., 2005), which itself activates the cycB–
Cdk1 complex by removing two inhibitory phosphoryla-
tions (Marumoto et al., 2005). This centrosomally activated
cycB-Cdk1 then triggers entry into mitosis (Jackman et al.,
2003).
Aur-A is activated by either autophosphorylation or
transphosphorylation on T288 in its activation domain. The
best characterized kinase involved in Aur-A phosphoryla-
tion is Pak; however, we show that Pak is not involved in the
Golgi checkpoint. This phosphorylation is not sufﬁcient for
the maintenance of Aur-A activation, because phosphatases
(e.g., PP1) rapidly dephosphorylate the T288 residue (Maru-
moto et al., 2005). This activity of phosphorylated Aur-A is
thus protected by its binding to scaffolding proteins, such as
the LIM-domain protein Ajuba (Hirota et al., 2003), the focal
adhesion scaffolding protein HEF1 (a member of the
p130Cas family; Pugacheva and Golemis, 2005), and the
microtubule-associated protein TPX2 (Bayliss et al., 2003).
Because Ajuba and HEF1 are focal-adhesion proteins, signif-
icant cross-talk between focal adhesions and the mitotic
apparatus has been proposed (Pugacheva and Golemis,
2006). It is possible that the disassembly of focal adhesions
releases these protein complexes, and leads to the activation
of Aur-A, thus coordinating the loss of adhesion to entry
into mitosis. However, depletion of HEF1 or Ajuba results in
inactivation of Aur-A, without affecting its recruitment to
the centrosome (Hirota et al., 2003; Pugacheva and Golemis,
2005); thus, HEF1 and Ajuba cannot be involved in the Golgi
checkpoint. The other Aurora-A activator, TPX2, is involved
in post-G2 targeting of Aur-A at the mitotic spindle appa-
ratus. Indeed, siRNA-mediated depletion of TPX2 abolishes
the association of Aur-A with the spindle, without affecting
its association with the centrosomes (Kufer et al., 2002).
The next key question is to understand why and how this
severing of the Golgi ribbon controls the recruitment of
Aur-A to the centrosome. One simple possibility is that the
Golgi membranes “sense” the mechanical tension exerted by
the separating centrosomes, and in the case of an unbroken
Golgi ribbon, could “emit” a stress signal to turn off recruit-
ment of Aur-A to the centrosomes. Alternatively, Aur-A
activation itself might be positively regulated by the sever-
ing of the Golgi ribbon. Indeed, even if the severing of the
Golgi ribbon results in only a minor acceleration of the
timing of mitotic entry and Aur-A recruitment/activation
(data not shown), Aur-A might function as a signaling hub.
Thus, Aur-A might integrate positive signals from various
inputs, among which there are those of the separating Golgi
membranes, which would all be required for sustained
Aur-A recruitment and activation. In this respect, Golgi
fragmentation during G2 might be “signaled” through re-
lease of proteins from the severed membranes that would
regulate the activation and/or recruitment of Aur-A during
early G2. This is analogous to the actions of clathrin or Nir2,
which are released from Golgi membranes during prophase
and which localize to the mitotic spindle and the midbody,
respectively, where they acquire new functions that are re-
lated to the formation of the mitotic spindle and cytokinesis
(Colanzi and Corda, 2007).
As a further possibility, the basis of the Golgi checkpoint
could be that an unbroken Golgi ribbon would impede the
Golgi membranes in their correct “positioning” with respect
to the separating centrosomes, an aspect that might be con-
nected with mechanisms controlling the geometrical preci-
sion of the planar orientation of cell division. This is an
essential feature that is critical during development and that
remains important for the maintenance of polarized struc-
tures in adults (Thery et al., 2006). Recent evidence suggests
that the nucleus, centrosome and Golgi complex are local-
ized along the axis of cell polarity, which is determined by
spatial cues provided by the geometry of cell–cell and/or
cell–extracellular matrix contacts (Thery et al., 2006). These
processes are coordinated at the centrosome through the
actions of proteins that regulate cytoskeleton organization
and function. Moreover, the Golgi/centrosome module is
reoriented toward the leading edge of the cell in migrating
Figure 10. The block of severing of the Golgi ribbon
during G2 inhibits the recruitment and activation of
Aur-A at the centrosome trough a novel mechanism.
(A) In mammalian cells, the Golgi complex is organized
as a continuous membranous system composed of
stacks interconnected by tubules, a structure known as
the Golgi ribbon (ribbon). During the G2 phase of the
cell cycle, the severing of the Golgi ribbon into its
constituent stacks (stacks) is a fragmentation step that is
essential for mitotic entrance and is concomitant with
the initial recruitment and activation of Aur-A kinase at
the centrosomes (CE). A block in Golgi fragmentation
(X) inhibits Aur-A recruitment and activation at the
centrosome, and this in turn impairs the ﬁrst activation
of cycB-Cdk1 at the centrosome. The Golgi-dependent
G2 block is not mediated by known Aur-A activators
(i.e., Pak1), and neither it is indirectly mediated or Plk1
and the cycB–Cdk1 complex. (B) The Golgi-dependent
G2 block is not regulated by known G2 checkpoint
mediators (e.g., : Chk1 or p38), and neither it is medi-
ated by Golgi-localized cell cycle regulators (e.g., : Myt-
1), which act downstream the Golgi checkpoint. (C) At
the onset of mitosis the kinases Aur-A, Plk1 and cycB-Cdk1 become functionally connected by a positive feedback loop, leading to irreversible
progression into mitosis.
Aurora-A Regulation by Golgi Partitioning
Vol. 21, November 1, 2010 3719ﬁbroblasts, and this function involves proteins such as
Cdc42 (Nobes and Hall, 1999), Par6 (Palazzo et al., 2001), and
GRASP65 (Bisel et al., 2008). Thus, the signaling pathways
that form the basis of the coordinated orientation of the
Golgi/centrosome module might be essential for a mecha-
nism that checks the correct reciprocal orientation of the
Golgi complex with respect to the separating centrosomes
during G2. Thus, an unbroken Golgi ribbon would interfere
with the correct positioning of the Golgi membranes, and
this could in turn interfere with the recruitment of Aur-A.
We have thus here identiﬁed the key cell cycle regulatory
element that connects the partitioning of the Golgi complex
to the molecular events involved in the initiation of mitosis,
although how the Golgi checkpoint affects the onset of
Aur-A activation remains to be determined. The identiﬁca-
tion of Aur-A as the cell cycle effector of the Golgi check-
point provides the basis for deﬁning the mechanisms by
which the Golgi complex can monitor its correct partitioning
and therefore control G2/M transition. These ﬁndings have
important physiological and pharmacological consequences,
because the deﬁnition of this pathway will lead to the iden-
tiﬁcation and validation of novel targets of antiproliferative
therapies and cancer treatments.
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